Improving decisions about the funding of high cost cancer medicines in Australia

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

In this project, we will address the pressing policy question: How can those funding cancer medicines manage the intensifying economic and ethical challenges that they face? Specifically, we will explore ways of making funding decisions fairer and more legitimate in the eyes of different stakeholders, including patients, the general public, governments and pharmaceutical companies. We will also consider ways in which these guidelines might be generalised to the funding of other medicines.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $569,303.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Bioethics (human and animal)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

ethics | pharmacotherapy | policy development | qualitative study | resource allocation